
Stocks Look To Close Out A Strong September… And GE Vernova’s Big Run Higher 9/27/24
CNBC's "Fast Money"
00:00
New Treatment Approval and Tesla's Rally Unpacked
This chapter explores the groundbreaking approval of a new schizophrenia treatment by Bristol-Myers, the first in seventy years, and its potential impact on the company's stock. It also examines Tesla's strong September performance and the factors contributing to its market rally ahead of critical Q3 delivery figures and the upcoming robo taxi launch.
Play episode from 18:46
Transcript


